Serious & Notifiable Infections — MCQs
On this page
A 52-year-old woman is diagnosed with smear-positive pulmonary tuberculosis. She has been taking warfarin for recurrent deep vein thrombosis secondary to antiphospholipid syndrome. Standard four-drug anti-tuberculous therapy is commenced. What is the most appropriate management of her anticoagulation?
A 38-year-old man with AIDS (CD4 count 35 cells/mm³) presents with a 4-week history of headache and fever. MRI brain shows multiple ring-enhancing lesions with surrounding oedema in both cerebral hemispheres. He is started on treatment for presumed cerebral toxoplasmosis. After how many days of appropriate anti-toxoplasma therapy should clinical and radiological response be assessed to determine if the diagnosis is correct?
A 26-year-old previously healthy woman presents to the emergency department with a 8-hour history of severe headache, fever (39.2°C), photophobia, and a non-blanching purpuric rash on her lower limbs. Blood pressure is 92/58 mmHg, heart rate 118 bpm. She is confused with GCS 13/15. What is the most appropriate immediate antibiotic management?
A 29-year-old woman from Ethiopia who migrated to the UK 6 months ago presents with a 12-week history of lower back pain, night sweats, and weight loss. MRI spine shows destruction of the T10-T11 vertebrae with paravertebral soft tissue collection and cord compression. What is the most appropriate initial management?
A 67-year-old man with chronic obstructive pulmonary disease presents with a 2-day history of fever, severe headache, and drowsiness. Lumbar puncture shows: white cells 2,400/mm³ (85% neutrophils), protein 3.2 g/L, glucose 1.4 mmol/L (plasma 7.8 mmol/L). Gram stain shows Gram-negative diplococci. He is started on intravenous ceftriaxone. Which additional immediate management is most important?
A 32-year-old man with no past medical history presents with a 10-week history of cough, weight loss, and night sweats. Chest X-ray shows bilateral upper zone cavitation. Three sputum samples are smear-positive for acid-fast bacilli. Culture and sensitivity results are pending. He lives with his pregnant wife (22 weeks gestation) and two children aged 3 and 7 years. What is the most appropriate immediate management for his household contacts?
A 45-year-old woman presents with a 3-week history of progressive headache, vomiting, and confusion. She has no significant past medical history. Lumbar puncture reveals: opening pressure 28 cmH₂O, CSF protein 2.4 g/L, glucose 1.8 mmol/L (plasma glucose 6.2 mmol/L), white cells 250/mm³ (90% lymphocytes). India ink stain is positive. What additional investigation is most important before starting treatment?
A 4-year-old child is diagnosed with tuberculous meningitis. Brain MRI shows basal meningeal enhancement and multiple tuberculomas. The child is started on appropriate anti-tuberculous therapy including rifampicin, isoniazid, pyrazinamide, and ethionamide. What is the recommended total duration of treatment for this child?
A 55-year-old man with newly diagnosed pulmonary tuberculosis is started on standard four-drug therapy. He has a background of gout for which he takes allopurinol. Two weeks into treatment, he develops a high fever, widespread erythematous rash with blistering, and painful mucosal ulceration affecting his mouth and eyes. Examination reveals extensive skin detachment affecting 40% of body surface area. What is the most likely causative drug?
A 23-year-old man presents with fever, severe headache, and neck stiffness. Lumbar puncture shows: white cells 2400 cells/mm³ (92% neutrophils), protein 3.1 g/L, glucose 0.8 mmol/L (plasma 5.2 mmol/L). Gram stain shows Gram-negative diplococci. He is treated with intravenous ceftriaxone and makes a good recovery. Blood PCR confirms Neisseria meningitidis serogroup B. Which statement regarding notification and prophylaxis is correct?
Serious & Notifiable Infections UK Medical PG Practice Questions and MCQs
Question 181: A 52-year-old woman is diagnosed with smear-positive pulmonary tuberculosis. She has been taking warfarin for recurrent deep vein thrombosis secondary to antiphospholipid syndrome. Standard four-drug anti-tuberculous therapy is commenced. What is the most appropriate management of her anticoagulation?
- A. Continue warfarin at the same dose and monitor INR weekly until stable
- B. Increase warfarin dose by 50% due to rifampicin interaction and monitor INR closely
- C. Switch to low molecular weight heparin for the duration of TB treatment (Correct Answer)
- D. Switch to a direct oral anticoagulant (DOAC) such as apixaban
- E. Stop anticoagulation as the thrombotic risk is lower during acute infection
Explanation: ***Switch to low molecular weight heparin for the duration of TB treatment***- **Rifampicin** is a potent inducer of **Cytochrome P450 enzymes**, which significantly accelerates **warfarin metabolism**, making the **INR** nearly impossible to stabilize.- **Low molecular weight heparin (LMWH)** is the safest choice because its metabolism is not affected by the **P450 system**, ensuring stable therapeutic anticoagulation for high-risk conditions like **Antiphospholipid Syndrome (APS)**.*Continue warfarin at the same dose and monitor INR weekly until stable*- Maintaining the same dose is dangerous as **Rifampicin** induction decreases warfarin levels rapidly, leading to a **subtherapeutic INR** and high risk of recurrent **thrombosis**.- Routine monitoring is often insufficient to keep up with the magnitude of the interaction, which can require **warfarin dose increases** of 2 to 3 times the baseline.*Increase warfarin dose by 50% due to rifampicin interaction and monitor INR closely*- While increasing the dose is a theoretical strategy, the enzyme induction is **variable and unpredictable**, making it difficult to achieve a stable **therapeutic window**.- This approach carries a high risk of **treatment failure** or sudden **toxicity** if other medications are adjusted or TB therapy is interrupted.*Switch to a direct oral anticoagulant (DOAC) such as apixaban*- **Rifampicin** induces **P-glycoprotein (P-gp)** and **CYP3A4**, which significantly reduces the plasma concentration and efficacy of **DOACs**.- Furthermore, **DOACs** are generally discouraged in patients with **Triple-Positive Antiphospholipid Syndrome** due to an increased risk of arterial thrombotic events compared to warfarin.*Stop anticoagulation as the thrombotic risk is lower during acute infection*- This is incorrect as **acute infection** and inflammation actually create a **pro-thrombotic state**, increasing the risk of VTE.- Stopping therapy in a patient with **recurrent DVT** and **Antiphospholipid Syndrome** is contraindicated due to the extremely high risk of life-threatening **thromboembolism**.
Question 182: A 38-year-old man with AIDS (CD4 count 35 cells/mm³) presents with a 4-week history of headache and fever. MRI brain shows multiple ring-enhancing lesions with surrounding oedema in both cerebral hemispheres. He is started on treatment for presumed cerebral toxoplasmosis. After how many days of appropriate anti-toxoplasma therapy should clinical and radiological response be assessed to determine if the diagnosis is correct?
- A. 7-10 days
- B. 3-5 days
- C. 10-14 days (Correct Answer)
- D. 21-28 days
- E. 6 weeks
Explanation: ***10-14 days***- In patients with **AIDS** and **multiple ring-enhancing lesions**, empirical therapy for **Toxoplasma gondii** is the standard first step, and a response is typically expected within **10-14 days**.- A lack of **clinical or radiological improvement** by the end of this period strongly suggests an alternative diagnosis, most commonly **Primary CNS Lymphoma (PCNSL)**.*3-5 days*- This duration is **too short** to observe significant radiological resolution of brain lesions and surrounding **oedema**.- Assessing too early may lead to unnecessary invasive procedures like a **brain biopsy** before the medication has had time to work.*7-10 days*- While some clinical improvement might start, **radiological assessment** at this stage is often premature and inconclusive.- Clinical guidelines specifically highlight the **two-week mark** (**10-14 days**) as the definitive window for evaluating treatment efficacy.*21-28 days*- Waiting nearly a month to assess response is dangerous, as it would cause a significant delay in diagnosing and treating **PCNSL** if toxoplasmosis is not the correct diagnosis.- If the diagnosis is incorrect, the patient's **neurological status** could deteriorate significantly during this prolonged observation period, increasing morbidity and mortality.*6 weeks*- This timeframe represents the typical duration of the **acute phase of induction therapy** for toxoplasmosis, not the initial assessment point for diagnostic confirmation.- Diagnosis verification must happen much earlier to ensure the patient is on the correct **antimicrobial or oncological regimen** and to prevent disease progression.
Question 183: A 26-year-old previously healthy woman presents to the emergency department with a 8-hour history of severe headache, fever (39.2°C), photophobia, and a non-blanching purpuric rash on her lower limbs. Blood pressure is 92/58 mmHg, heart rate 118 bpm. She is confused with GCS 13/15. What is the most appropriate immediate antibiotic management?
- A. Intravenous ceftriaxone 2g plus intravenous amoxicillin 2g
- B. Intravenous ceftriaxone 2g alone (Correct Answer)
- C. Intramuscular benzylpenicillin 1.2g
- D. Intravenous ceftriaxone 2g plus intravenous vancomycin 1g
- E. Intravenous meropenem 2g plus intravenous vancomycin 1g
Explanation: ***Intravenous ceftriaxone 2g alone*** - This patient presents with classic **meningococcal disease**, characterized by fever, headache, meningism, and a **non-blanching purpuric rash**, along with signs of sepsis. - **Intravenous ceftriaxone** is the first-line empirical treatment in adults aged 18-50 as it effectively covers **Neisseria meningitidis** and **Streptococcus pneumoniae**, the most common pathogens in community-acquired bacterial meningitis in this age group. *Intravenous ceftriaxone 2g plus intravenous amoxicillin 2g* - **Amoxicillin** is added to cover **Listeria monocytogenes**, which typically affects neonates, the elderly (>50-60 years), pregnant women, or **immunocompromised** patients. - Since this patient is a **previously healthy 26-year-old**, empirical coverage for Listeria is not routinely indicated. *Intramuscular benzylpenicillin 1.2g* - This is primarily used in the **pre-hospital setting** by GPs or paramedics when **bacterial meningitis** is suspected and transfer to a hospital is delayed. - Once in the **Emergency Department**, intravenous broad-spectrum cephalosporins like **ceftriaxone** are the preferred standard of care due to broader coverage and route of administration. *Intravenous ceftriaxone 2g plus intravenous vancomycin 1g* - **Vancomycin** is usually added in regions with a high prevalence of **penicillin-resistant pneumococcus** or if the patient has specific risk factors (e.g., recent antibiotic use, history of resistant organisms). - It is not part of the standard initial empirical regimen for a healthy young adult with suspected community-acquired meningococcal sepsis in many regions. *Intravenous meropenem 2g plus intravenous vancomycin 1g* - **Meropenem** is a very broad-spectrum carbapenem typically reserved for **healthcare-associated meningitis**, severe **beta-lactam allergies**, or very resistant organisms. - This combination provides excessive coverage for **community-acquired meningitis** in a young, immunocompetent patient without specific risk factors.
Question 184: A 29-year-old woman from Ethiopia who migrated to the UK 6 months ago presents with a 12-week history of lower back pain, night sweats, and weight loss. MRI spine shows destruction of the T10-T11 vertebrae with paravertebral soft tissue collection and cord compression. What is the most appropriate initial management?
- A. Start four-drug anti-tuberculous therapy and arrange urgent neurosurgical assessment (Correct Answer)
- B. Perform CT-guided biopsy of the paravertebral collection before starting treatment
- C. Start four-drug anti-tuberculous therapy and refer for outpatient physiotherapy
- D. Arrange urgent surgical debridement and spinal stabilization before starting anti-tuberculous therapy
- E. Start empirical broad-spectrum antibiotics for pyogenic osteomyelitis
Explanation: ***Start four-drug anti-tuberculous therapy and arrange urgent neurosurgical assessment*** - The patient's presentation with chronic back pain, night sweats, weight loss, vertebral destruction, and a paravertebral collection in a person from an endemic area is highly suggestive of **Pott's disease** (spinal tuberculosis). - **Cord compression** is a medical emergency requiring immediate initiation of **anti-tuberculous therapy** to control the infection and an urgent neurosurgical assessment to prevent permanent neurological deficits. *Perform CT-guided biopsy of the paravertebral collection before starting treatment* - While tissue diagnosis is important, delaying treatment for a biopsy when **neurological compromise** (cord compression) is present is inappropriate. - Empirical **anti-tuberculous therapy** should be started immediately based on high clinical and radiological suspicion in such urgent cases. *Start four-drug anti-tuberculous therapy and refer for outpatient physiotherapy* - Physiotherapy is a supportive measure but does not address the urgent need to manage **cord compression** or spinal instability. - Outpatient referral is insufficient as the patient requires inpatient monitoring and immediate intervention for their severe condition. *Arrange urgent surgical debridement and spinal stabilization before starting anti-tuberculous therapy* - Surgical intervention may be required, but it is generally performed *after* or concurrently with the initiation of **anti-tuberculous therapy**. - Starting medical therapy first helps to reduce the risk of **disease dissemination** during the surgical procedure. *Start empirical broad-spectrum antibiotics for pyogenic osteomyelitis* - The chronic 12-week history and constitutional symptoms (night sweats, weight loss) are more indicative of **tuberculosis** rather than acute pyogenic osteomyelitis. - The patient's origin from an **endemic region** for tuberculosis further points away from empirical treatment for pyogenic osteomyelitis.
Question 185: A 67-year-old man with chronic obstructive pulmonary disease presents with a 2-day history of fever, severe headache, and drowsiness. Lumbar puncture shows: white cells 2,400/mm³ (85% neutrophils), protein 3.2 g/L, glucose 1.4 mmol/L (plasma 7.8 mmol/L). Gram stain shows Gram-negative diplococci. He is started on intravenous ceftriaxone. Which additional immediate management is most important?
- A. Add intravenous dexamethasone (Correct Answer)
- B. Add intravenous vancomycin
- C. Arrange repeat lumbar puncture in 48 hours
- D. Give intramuscular benzylpenicillin
- E. Notify public health authorities
Explanation: ***Add intravenous dexamethasone***- High-level evidence and clinical guidelines recommend **dexamethasone** should be administered with or just before the first dose of antibiotics in suspected **bacterial meningitis** to reduce inflammation.- It significantly decreases the risk of **neurological sequelae** and mortality by dampening the inflammatory response to bacterial lysis in the subarachnoid space.*Add intravenous vancomycin*- **Vancomycin** is typically added empirically if there is a suspicion of **penicillin-resistant Streptococcus pneumoniae**, which is not indicated by the Gram-negative diplococci seen here.- The Gram stain specifically points toward **Neisseria meningitidis**, for which **ceftriaxone** provides excellent coverage without the need for vancomycin.*Arrange repeat lumbar puncture in 48 hours*- A **repeat lumbar puncture** is not routinely recommended unless there is a failure to respond clinically to appropriate therapy after 48 hours.- Immediate management focuses on stabilizing the patient and preventing complications, not scheduled **CSF surveillance** in the acute phase.*Give intramuscular benzylpenicillin*- **IM benzylpenicillin** is primarily used as a pre-hospital treatment in the community when **meningococcal septicaemia** is suspected and hospital transfer is delayed.- Since the patient is already in the hospital receiving **intravenous ceftriaxone**, benzylpenicillin provides no additional benefit and is pharmacologically redundant.*Notify public health authorities*- While **notifying public health** is a mandatory statutory requirement for cases of **meningococcal disease**, it is not an immediate clinical priority for patient stabilization.- Clinical management to prevent **hearing loss** and brain injury (using steroids) takes precedence over administrative reporting in the immediate setting.
Question 186: A 32-year-old man with no past medical history presents with a 10-week history of cough, weight loss, and night sweats. Chest X-ray shows bilateral upper zone cavitation. Three sputum samples are smear-positive for acid-fast bacilli. Culture and sensitivity results are pending. He lives with his pregnant wife (22 weeks gestation) and two children aged 3 and 7 years. What is the most appropriate immediate management for his household contacts?
- A. All household contacts should receive isoniazid prophylaxis immediately
- B. Chest X-ray for all contacts, Mantoux test for children, prophylaxis only if tests abnormal
- C. Mantoux test for all contacts, treat those with positive results
- D. Observe all contacts clinically, arrange follow-up in 8 weeks for reassessment
- E. Chest X-ray for wife, Mantoux test and prophylaxis for both children regardless of results (Correct Answer)
Explanation: ***Chest X-ray for wife, Mantoux test and prophylaxis for both children regardless of results*** - In smear-positive pulmonary TB cases, children **under 5 years** (like the 3-year-old) must receive immediate **chemoprophylaxis** after excluding active disease, regardless of initial test results, due to high risk of progression to **miliary TB or meningitis**. - The pregnant wife requires a **chest X-ray** (with shielding) as the first step to exclude active disease, while older children (like the 7-year-old) require **Mantoux testing** to determine if treatment for latent infection is necessary. *All household contacts should receive isoniazid prophylaxis immediately* - Prophylaxis is not given blindly to all adults; active TB must be **excluded first** using imaging or clinical assessment to avoid under-treating active disease. - For the wife and the 7-year-old, the decision to give prophylaxis typically depends on **screening results** (Mantoux or CXR) rather than being immediate and universal. *Chest X-ray for all contacts, Mantoux test for children, prophylaxis only if tests abnormal* - This approach is incorrect for the 3-year-old, as current guidelines mandate **primary prophylaxis** for children under 5 even if the initial Mantoux is negative. - Waiting for "abnormal tests" in very young children is dangerous because they can develop **disseminated disease** during the window period before a skin test becomes positive. *Mantoux test for all contacts, treat those with positive results* - This ignores the high-risk status of the **under-5 age group**, who require protection regardless of the initial Mantoux result during the "window period." - It also overlooks that a **chest X-ray** is the preferred initial screening tool for symptomatic or high-risk adults (like the wife) to rapidly rule out infectiousness. *Observe all contacts clinically, arrange follow-up in 8 weeks for reassessment* - Clinical observation alone is insufficient for **household contacts** of a smear-positive index case, which carries a very high transmission risk. - Delaying intervention by 8 weeks would miss the critical window to prevent **latent TB progression** in the vulnerable children.
Question 187: A 45-year-old woman presents with a 3-week history of progressive headache, vomiting, and confusion. She has no significant past medical history. Lumbar puncture reveals: opening pressure 28 cmH₂O, CSF protein 2.4 g/L, glucose 1.8 mmol/L (plasma glucose 6.2 mmol/L), white cells 250/mm³ (90% lymphocytes). India ink stain is positive. What additional investigation is most important before starting treatment?
- A. CT chest to exclude pulmonary tuberculosis
- B. HIV test (Correct Answer)
- C. Serum cryptococcal antigen
- D. MRI brain with gadolinium contrast
- E. Tuberculin skin test
Explanation: ***HIV test*** - A **positive India ink stain** confirms **cryptococcal meningitis**, a defining opportunistic infection that rarely occurs in immunocompetent individuals. - Identifying **HIV status** is critical as it dictates the specific **treatment protocols**, timing of antiretroviral therapy, and management of **immune reconstitution inflammatory syndrome (IRIS)**. *CT chest to exclude pulmonary tuberculosis* - While **pulmonary TB** can coexist with HIV, the immediate diagnosis here is confirmed as fungal via **India ink**, making TB workup less urgent than baseline immune status evaluation. - **Lymphocytic pleocytosis** and low glucose profile overlap with TB, but the presence of **encapsulated yeasts** directs the primary focus away from tuberculosis. *Serum cryptococcal antigen* - This test is highly sensitive for screening but is redundant for primary diagnosis when **CSF India ink** and biochemical analysis have already confirmed the presence of the organism. - It may be used for **prognostication** or monitoring, but does not provide the essential underlying immune status information required for comprehensive management. *MRI brain with gadolinium contrast* - MRI is useful to identify complications like **cryptococcomas** or stroke but is not an essential investigation *before* starting induction antifungal therapy. - Although it may show **leptomeningeal enhancement**, the clinical and laboratory data provided are sufficient for immediate therapeutic intervention. *Tuberculin skin test* - The **Tuberculin skin test (Mantoux)** is often falsely negative (**anergy**) in patients with advanced immunosuppression or active meningitis. - It does not assist in the immediate management or confirmation of the **fungal etiology** established by the CSF findings.
Question 188: A 4-year-old child is diagnosed with tuberculous meningitis. Brain MRI shows basal meningeal enhancement and multiple tuberculomas. The child is started on appropriate anti-tuberculous therapy including rifampicin, isoniazid, pyrazinamide, and ethionamide. What is the recommended total duration of treatment for this child?
- A. 6 months with four drugs throughout
- B. 9 months with initial four-drug phase for 2 months
- C. 12 months with initial four-drug phase for 2 months (Correct Answer)
- D. 18 months with initial four-drug phase for 2 months
- E. 24 months with initial four-drug phase for 3 months
Explanation: ***12 months with initial four-drug phase for 2 months*** - Standard treatment for **tuberculous meningitis** in children consists of a **2-month intensive phase** with four drugs (rifampicin, isoniazid, pyrazinamide, ethionamide) followed by a **10-month continuation phase**, totaling **12 months**. - This prolonged duration is crucial for adequate **central nervous system** penetration and sterilization, especially given the presence of **basal meningeal enhancement** and **tuberculomas**, which indicate severe disease. *6 months with four drugs throughout* - A **6-month regimen** is standard for uncomplicated pulmonary tuberculosis but is generally insufficient for severe **extrapulmonary TB**, particularly involving the **central nervous system**. - A shorter duration carries a higher risk of **relapse**, poor neurological outcomes, and the development of **drug resistance** in CNS TB. *9 months with initial four-drug phase for 2 months* - While a **9-month regimen** is sometimes used for less severe forms of **extrapulmonary TB** (e.g., bone and joint TB), it is not the recommended duration for **tuberculous meningitis**. - The severity and potential sequelae of CNS involvement necessitate a longer treatment course to ensure complete eradication and prevent neurological damage. *18 months with initial four-drug phase for 2 months* - An **18-month regimen** is typically reserved for cases of **multi-drug resistant (MDR-TB)** or highly complicated, extensive lesions with a very slow clinical response. - For drug-susceptible **tuberculous meningitis**, **12 months** is the established total duration, with longer regimens increasing the risk of **drug toxicity** without clear additional benefit. *24 months with initial four-drug phase for 3 months* - A **24-month duration** is excessively long for drug-susceptible **tuberculous meningitis** and significantly increases the risk of **adverse drug reactions** and poor adherence. - The intensive phase for pediatric TB meningitis is standardly **2 months**, not 3 months, before transitioning to a continuation phase.
Question 189: A 55-year-old man with newly diagnosed pulmonary tuberculosis is started on standard four-drug therapy. He has a background of gout for which he takes allopurinol. Two weeks into treatment, he develops a high fever, widespread erythematous rash with blistering, and painful mucosal ulceration affecting his mouth and eyes. Examination reveals extensive skin detachment affecting 40% of body surface area. What is the most likely causative drug?
- A. Ethambutol
- B. Isoniazid
- C. Pyrazinamide (Correct Answer)
- D. Rifampicin
- E. Streptomycin
Explanation: ***Pyrazinamide*** - This patient presents with **Toxic Epidermal Necrolysis (TEN)**, defined by high fever, widespread blistering, painful mucosal ulceration, and extensive skin detachment affecting **40% body surface area**. - Among antitubercular drugs, **Pyrazinamide** is the most frequently associated with severe cutaneous adverse reactions like **SJS/TEN**, and the risk is significantly potentiated by concurrent **allopurinol** use. *Ethambutol* - The primary dose-dependent toxicity of this drug is **optic neuritis**, leading to decreased visual acuity and **red-green color blindness**. - While it can cause mild rashes, it is extremely rare for it to cause life-threatening **epidermal necrolysis**. *Isoniazid* - Most commonly associated with **hepatotoxicity** and **peripheral neuropathy** due to pyridoxine (Vitamin B6) deficiency. - Although it can cause hypersensitivity, it does not typically present with the dramatic **mucocutaneous detachment** seen in this patient. *Rifampicin* - Frequently causes minor side effects like **orange discoloration of secretions** and gastrointestinal upset, or more serious **cholestatic jaundice**. - While rarely implicated in skin reactions, it is much less common than **Pyrazinamide** as a trigger for **TEN**. *Streptomycin* - An aminoglycoside mainly associated with **ototoxicity** (vestibular and auditory damage) and **nephrotoxicity**. - It is not part of the standard initial four-drug oral regimen (RIPE) and is not known for causing **TEN**.
Question 190: A 23-year-old man presents with fever, severe headache, and neck stiffness. Lumbar puncture shows: white cells 2400 cells/mm³ (92% neutrophils), protein 3.1 g/L, glucose 0.8 mmol/L (plasma 5.2 mmol/L). Gram stain shows Gram-negative diplococci. He is treated with intravenous ceftriaxone and makes a good recovery. Blood PCR confirms Neisseria meningitidis serogroup B. Which statement regarding notification and prophylaxis is correct?
- A. This is a notifiable disease; the laboratory will notify Public Health and arrange contact prophylaxis
- B. This is a notifiable disease; the treating clinician must notify the local Health Protection Team urgently (Correct Answer)
- C. Notification is only required if the patient dies or has long-term complications
- D. This is not a notifiable disease as the patient has recovered with treatment
- E. Notification is only required for serogroups A, C, W, and Y, not serogroup B
Explanation: ***This is a notifiable disease; the treating clinician must notify the local Health Protection Team urgently*** - **Meningococcal disease** is a legally notifiable condition, and the primary responsibility for notification rests with the **attending clinician** upon clinical suspicion. - Urgent notification to the **Health Protection Team (HPT)** is mandatory to facilitate rapid **contact tracing** and the administration of **chemoprophylaxis** to close contacts within 24 hours. *This is a notifiable disease; the laboratory will notify Public Health and arrange contact prophylaxis* - While laboratories have a duty to report identified pathogens, the **legal obligation** for urgent clinical notification remains with the **clinician**. - The **Health Protection Team**, rather than the laboratory staff, is responsible for coordinating the assessment and provision of **prophylaxis** to contacts. *Notification is only required if the patient dies or has long-term complications* - Notification is required for **all suspected and confirmed cases** of meningococcal disease, regardless of clinical outcome or severity. - Clinical notification should occur as soon as the diagnosis is suspected to prevent **secondary cases**, not following recovery or death. *This is not a notifiable disease as the patient has recovered with treatment* - The **notifiable status** of a disease is based on its public health risk and potential for outbreaks, which is not altered by the patient's individual **recovery**. - Recovery does not eliminate the need for **epidemiological surveillance** or the protection of close contacts who may still be at risk. *Notification is only required for serogroups A, C, W, and Y, not serogroup B* - **All serogroups** of *Neisseria meningitidis* are strictly notifiable under public health regulations. - Serogroup B remains a significant cause of **meningitis and septicaemia**, and cases trigger the same urgent **public health response** as other serogroups.
Practice by Chapter
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free